ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
186 hedge funds and large institutions have $2.05B invested in Acorda Therapeutics in 2015 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 67 increasing their positions, 70 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 70
26% less call options, than puts
Call options by funds: $10.2M | Put options by funds: $13.8M
Holders
186
Holding in Top 10
4
Calls
$10.2M
Puts
$13.8M
Top Buyers
| 1 | +$106M | |
| 2 | +$59.3M | |
| 3 | +$41.8M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$16M |
| 5 |
Jennison Associates
New York
|
+$14.2M |
Top Sellers
| 1 | -$79.5M | |
| 2 | -$39.8M | |
| 3 | -$14M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$10.5M |
| 5 |
Barclays
London,
United Kingdom
|
-$10.5M |